These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 5367304)

  • 1. The pharmacological effects of an unusual hypotensive agent: (SK & F 11197, 2,6-diamino-4-dimethylamino-ethoxy pyrimidine). I. Effects on the cardiovascular system.
    Ehrreich SJ; Heringslake JE; Warren FR; Weinstock J; Tedeschi RE
    Arch Int Pharmacodyn Ther; 1969 Jun; 179(2):284-302. PubMed ID: 5367304
    [No Abstract]   [Full Text] [Related]  

  • 2. Analysis of the hypotensive action of prazosin.
    Constantine JW; McShane WK; Scriabine A; Hess HJ
    Postgrad Med; 1975 Nov; Spec No():18-35. PubMed ID: 1197141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. General pharmacologic actions of the antihypertensive agent 2,6-dichlorobenzylidene aminoguanidine acetate (WY-8678).
    Baum T; Shropshire AT; Rowles G; Van Pelt R; Fernandez SP; Eckfeld DK; Gluckman MI
    J Pharmacol Exp Ther; 1970 Feb; 171(2):276-87. PubMed ID: 5466490
    [No Abstract]   [Full Text] [Related]  

  • 4. Cardiovascular effects of a novel vasoactive antihypertensive agent, Ro 12-4713.
    Gerold M; Eigenmann R; Hefti F; Daum A; Haeusler G
    J Pharmacol Exp Ther; 1981 Mar; 216(3):624-33. PubMed ID: 7009831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Some cardiovascular effects of timolol a new beta-adrenergic blocking agent.
    Scriabine A; Torchiana ML; Stavorski JM; Ludden CT; Minsker DH; Stone CA
    Arch Int Pharmacodyn Ther; 1973 Sep; 205(1):76-93. PubMed ID: 4148410
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative profile of L 3428 and other antianginal agents on cardiac hemodynamics.
    Petta JM; Zaccheo VJ
    J Pharmacol Exp Ther; 1971 Feb; 176(2):328-38. PubMed ID: 4998691
    [No Abstract]   [Full Text] [Related]  

  • 7. The pharmacology of SK & F 11197 (2,6 diamino-4-dimethylaminoethoxy pyrimidine), an unusual hypotensive agent. II. Mode of action studies.
    Ehrreich SJ; Heringslake JE; Jablonski R; Weinstock J; Tedeschi RE
    Arch Int Pharmacodyn Ther; 1969 Jun; 179(2):303-13. PubMed ID: 4391610
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacology of Go-1002.
    Grewal RS; Kaul CL; David J
    J Pharmacol Exp Ther; 1968 Apr; 160(2):268-76. PubMed ID: 4384786
    [No Abstract]   [Full Text] [Related]  

  • 9. Regional blood flow and cardiac responses to hydralazine.
    Spokas EG; Wang HH
    J Pharmacol Exp Ther; 1980 Feb; 212(2):294-303. PubMed ID: 7351643
    [No Abstract]   [Full Text] [Related]  

  • 10. Cardiovascular pharmacology of two new beta-adrenergic receptor antagonists.
    Stanton HC; Kirchgessner T; Parmenter K
    J Pharmacol Exp Ther; 1965 Aug; 149(2):174-82. PubMed ID: 4378559
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of acute administration of 2-amino-4-(3,4-dichlorophenyl)-2-imidazoline HBr (MJ 10459-2) or guanethidine on selected sympathetically-mediated responses in the anesthetized dog and cat.
    Deitchman D; Gomoll AW; Snyder RW; Preston JE
    Arch Int Pharmacodyn Ther; 1974 Aug; 210(2):268-78. PubMed ID: 4441194
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of brotizolam on cardiovascular functions and autonomic nervous system.
    Kushiku K; Morishita H; Furukawa T; Kitagawa H; Ueno K; Kitagawa H; Kohei H
    Arzneimittelforschung; 1986 Mar; 36(3A):552-9. PubMed ID: 3718577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the pharmacology of guanoxan.
    Vidal-Beretervide K; Pritsch LE; Trinidad H
    Arzneimittelforschung; 1969 Jun; 19(6):947-51. PubMed ID: 4389903
    [No Abstract]   [Full Text] [Related]  

  • 14. Cardiovascular profile of mixidine fumarate, a compound which attenuates myocardial chronotropic responses.
    Pruss TP; Hageman WE; Jacoby HI
    J Pharmacol Exp Ther; 1980 Mar; 212(3):514-8. PubMed ID: 7359351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Some acute hemodynamic effects of large doses of sodium allopurinol in open-chested dogs.
    Ellis CH; Touw KB; Dickerson SW
    Arch Int Pharmacodyn Ther; 1973 Oct; 205(2):355-67. PubMed ID: 4766552
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hemodynamic properties of a new derivative of theophylline: bamifylline].
    Moret PR; Fournet PC; Boufas D
    Schweiz Med Wochenschr; 1970 Mar; 100(10):462-7. PubMed ID: 5423732
    [No Abstract]   [Full Text] [Related]  

  • 17. General pharmacology of the novel angiotensin converting enzyme inhibitor alacepril. 1st communication: Effects on cardiovascular, visceral and renal functions and on blood.
    Matsuno Y; Taira N; Fujitani B; Ito T; Kadokawa T
    Arzneimittelforschung; 1986; 36(1):55-62. PubMed ID: 3513777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic and coronary hemodynamic effects of perhexiline.
    Rowe GG; Spring DA; Afonso S
    Arch Int Pharmacodyn Ther; 1970 Oct; 187(2):377-93. PubMed ID: 4921275
    [No Abstract]   [Full Text] [Related]  

  • 19. Systemic and coronary hemodynamic effects of pinacidil, a new antihypertensive agent, in awake dogs: comparison with hydralazine.
    Kawashima S; Liang CS
    J Pharmacol Exp Ther; 1985 Feb; 232(2):369-75. PubMed ID: 3968638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies relating to the antihypertensive and antidysrhythmic action of indoramin.
    Baum T; Shropshire AT; Eckfeld DK; Metz N; Dinish JL; Peters JR; Butz F; Gluckman MI
    Arch Int Pharmacodyn Ther; 1973 Aug; 204(2):390-406. PubMed ID: 4356047
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.